Intervention

Diagnostic test

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting1

Common conditions11

Lead sponsors shown5

Clinical trials

5 shown

Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant ChemotherapyNCT06299202 · 2024-08-23

Interest of sFlt1/PlGF Ratio at Obstetric EmergenciesNCT04170660 · 2019-11-18

Enhanced FoCUS in Patients With Shortness of BreathNCT05403619 · 2018-01-01

Combined Breast Cancer Risk StudyNCT03067389 · 2016-02-06

Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung AdenocarcinomaNCT03641105 · 2014-01-01

Common conditions

Acute Respiratory Failure1 Breast Cancer1 Diagnosis1 Glycolysis1 Hereditary Cancer1 Lung Cancer1 Pre-Eclampsia1 Pregnancy Complications1 Shortness of Breath1 Survival1 Suspected Placental Dysfunction, Ruled Out1

Leading sponsors

Centre Hospitalier Intercommunal Creteil1 Hospices Civils de Lyon1 Myriad Genetic Laboratories, Inc.1 Nantes University Hospital1 Shanghai Zhongshan Hospital1

Trial status mix

COMPLETED2

UNKNOWN2

RECRUITING1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.